Maxalt Lingua Migräne (Rizatriptan Benzoate)

• Rizatriptan benzoate is a Triptan medication used to treat migraine by targeting serotonin receptors.
• Migraine with aura: provides rapid relief of headache pain and associated neurological symptoms.
• Migraine without aura: reduces headache intensity and shortens attack duration.
• Acute migraine attacks: aborts attacks when taken at the first sign of a migraine.

• Rizatriptan benzoate selectively binds to serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve terminals. Activation causes vasoconstriction of intracranial arteries and inhibits release of pro‑pain neuropeptides, thereby interrupting the migraine pain pathway.

Rizatriptan benzoate may cause a range of adverse reactions, which are generally classified as common or serious.

Common Side Effects

• Taste disturbance: altered or unpleasant taste after spray.
• Oral tingling: mild numbness or tingling in the mouth.
• Nausea: feeling of queasiness.
• Dizziness: light‑headed sensation.
• Fatigue: transient tiredness.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Chest pain or tightness: possible cardiac ischemia.
• Serotonin syndrome: agitation, hyperthermia, muscle rigidity.
• Severe allergic reaction (anaphylaxis): swelling, difficulty breathing.
• Ischemic cardiac events: myocardial infarction in susceptible patients.
• Persistent visual disturbances: prolonged aura symptoms.
• Severe hypertension: sudden rise in blood pressure.

• Before prescribing Maxalt Lingua Migräne, clinicians should consider several safety factors.
• Medical history review: assess cardiovascular disease, hypertension, or cerebrovascular disorders.
• Concomitant serotonergic drugs: avoid combined use due to risk of serotonin syndrome.
• Pregnancy and lactation: discuss potential risks with a healthcare provider as safety data are limited.
• Age considerations: not recommended for patients under 18 years of age.
• Renal or hepatic impairment: dose adjustment may be required based on organ function.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Rizatriptan benzoate can interact with several medication classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

• MAO inhibitors: risk of severe hypertension.
• Other triptans or ergotamines: additive vasoconstriction may precipitate ischemia.
• SSRIs/SNRIs: potential for serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma concentrations of rizatriptan.
• CYP3A4 inducers (e.g., rifampin): may reduce therapeutic effectiveness.